Call now, or fill out the form below, for more information.

305-698-4500 Mon – Fri 8am-5pm

Now Enrolling:

Chikungunya Virus Vaccine

Clinical Trial

Call Us: 305-698-4500

Chikungunya Vaccine Study

Chikungunya is a virus that can be spread through mosquito bites similar to other mosquito-spread illnesses like Zika, malaria, dengue, and West Nile Virus. Panax Clinical Research is conducting a study to test the effectiveness of a phase 3 vaccine to prevent Chikungunya in people who are 65 or older. The study will be 7 months long and consists of 5 office visits and 2 phone call appointments.
Ages: 65+
Compensation: $950*
Study Topic: Chikungunya Virus

*Compensation for time and travel may be available to those who qualify.